Acute primary subjective tinnitus
Conditions
Interventions
Yuekangtong extract of ginkgo biloba leaves injection group:none
Sponsors
Beijing Tongren Hospital Affiliated to Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1.When signing the informed consent form, the age of subject is 18-65 years old (including 18 and 65 years old), either gender; 2.The subject of acute primary subjective tinnitus; (1) The course of disease is within 3 months; (2) Without definite disease (including the whole or part bodys' reason); (3) The tinnitus is only heard by subject; (4) With or without hearing loss. 3.The subject signs the informed consent form.
Exclusion criteria
Exclusion criteria: 1.The subject with External middle ear lesions, Meniere's disease, acoustic neuroma and large vestibular aqueduct syndrome etc; 2.The subject with severe heart disease, coagulation or platelet dysfunction, bleeding tendency, severe liver or kidney dysfunction [ALT or AST > 2.0 ULN, and/or serum creatinine > 2.0 ULN], and serious diseases affecting their survival; 3.The subject with severe mental illness, severe cognitive dysfunction and so on, couldn't or is unwilling to cooperate; 4.The subject is allergic to the study drug or with medical history of serious adverse reaction; 5.Pregnant women, women planning pregnancy or lactating women; 6.The subject who the investigator considers is not suitable to this clinical study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tinnitus Handicap Inventory (THI); | — |
Secondary
| Measure | Time frame |
|---|---|
| Hospital Anxiety and Depression Scale (HADS);Adeverse events; | — |
Countries
China
Contacts
Public ContactHan Demin; Huang Zhigang; Li Yongxin
Beijing Tongren Hospital, CMU
Outcome results
None listed